Request Deal Involvement

Carlyle and Atmas Health completed the acquisition of the Vantive kidney care segment of Baxter for $3.8bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

CMS

legal advisors

CMS

Goldman Sachs

financial advisors

Goldman Sachs

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Barclays

financial advisors

Barclays

JP Morgan

financial advisors

JP Morgan

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Baker McKenzie

legal advisors

Baker McKenzie

White & Case

legal advisors

White & Case

Trench Rossi e Watanabe

legal advisors

Trench Rossi e Watanabe

or

Principals

VANTIVE (BAXTER KIDNEY CARE SEGMENT)

target

VANTIVE (BAXTER KIDNEY CARE SEGMENT)

THE CARLYLE GROUP

bidder

THE CARLYLE GROUP

BAXTER INTERNATIONAL INC

vendor

BAXTER INTERNATIONAL INC

ATMAS HEALTH

bidder

ATMAS HEALTH

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite